CARISMA Therapeutics Inc (OTCPK:CARM)
$ 0.0081 +0.00010 (+1.25%) Market Cap: 339,000.00 Enterprise Value: -1.68 Mil PE Ratio: 0.04 PB Ratio: 0 GF Score: 0/100

Q3 2020 Sesen Bio Inc Earnings Call Transcript

Nov 09, 2020 / 01:00PM GMT
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Sesen Bio Third Quarter 2020 Business Update Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Ms. Erin Clark. Thank you. Please go ahead, madam.

Erin Clark
Sesen Bio, Inc. - VP of Corporate Strategy & IR

Thank you, and good morning, everyone. Welcome to our third quarter business update call. On today's call, we will discuss our operating results for the third quarter ending September 30, 2020, as well as an update on the progress of studies related to affecting analytical comparability between clinical batches of Vicinium and commercial material, which is a key component of completing module 3 and finalizing the BLA submission.

Joining me on today's call are Dr. Thomas Cannell, President and Chief Executive Officer; Dr. Chad Myskiw, Executive Director of Supply Chain; and Monica Forbes, our Chief Financial Officer.

Earlier this morning, we issued a press release outlining some of the highlights that will be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot